vs
LifeStance Health Group, Inc.（LFST）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是LifeStance Health Group, Inc.的1.0倍（$384.8M vs $382.2M）。LifeStance Health Group, Inc.净利率更高（3.1% vs -19.6%，领先22.7%）。LifeStance Health Group, Inc.同比增速更快（17.4% vs 3.8%）。过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs -0.5%）
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
LFST vs PIII — 直观对比
营收规模更大
PIII
是对方的1.0倍
$382.2M
营收增速更快
LFST
高出13.6%
3.8%
净利率更高
LFST
高出22.7%
-19.6%
两年增速更快
LFST
近两年复合增速
-0.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $382.2M | $384.8M |
| 净利润 | $11.7M | $-75.5M |
| 毛利率 | — | — |
| 营业利润率 | 4.7% | -40.0% |
| 净利率 | 3.1% | -19.6% |
| 营收同比 | 17.4% | 3.8% |
| 净利润同比 | 264.1% | -28.8% |
| 每股收益（稀释后） | — | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFSTPIII
| Q4 25 | $382.2M | $384.8M | ||
| Q3 25 | $363.8M | $345.3M | ||
| Q2 25 | $345.3M | $355.8M | ||
| Q1 25 | $333.0M | $373.2M | ||
| Q4 24 | $325.5M | $370.7M | ||
| Q3 24 | $312.7M | $362.1M | ||
| Q2 24 | $312.3M | $379.2M | ||
| Q1 24 | $300.4M | $388.5M |
净利润LFSTPIII
| Q4 25 | $11.7M | $-75.5M | ||
| Q3 25 | $1.1M | $-31.6M | ||
| Q2 25 | $-3.8M | $-20.4M | ||
| Q1 25 | $709.0K | $-20.5M | ||
| Q4 24 | $-7.1M | $-58.6M | ||
| Q3 24 | $-6.0M | $-46.5M | ||
| Q2 24 | $-23.3M | $-12.0M | ||
| Q1 24 | $-21.1M | $-18.7M |
营业利润率LFSTPIII
| Q4 25 | 4.7% | -40.0% | ||
| Q3 25 | 2.0% | -12.8% | ||
| Q2 25 | -0.9% | -9.6% | ||
| Q1 25 | 0.5% | -10.2% | ||
| Q4 24 | 0.3% | -37.4% | ||
| Q3 24 | 0.0% | -29.5% | ||
| Q2 24 | -5.1% | -8.3% | ||
| Q1 24 | -5.6% | -11.3% |
净利率LFSTPIII
| Q4 25 | 3.1% | -19.6% | ||
| Q3 25 | 0.3% | -9.1% | ||
| Q2 25 | -1.1% | -5.7% | ||
| Q1 25 | 0.2% | -5.5% | ||
| Q4 24 | -2.2% | -15.8% | ||
| Q3 24 | -1.9% | -12.8% | ||
| Q2 24 | -7.5% | -3.2% | ||
| Q1 24 | -7.0% | -4.8% |
每股收益（稀释后）LFSTPIII
| Q4 25 | — | $-23.08 | ||
| Q3 25 | — | $-9.67 | ||
| Q2 25 | — | $-6.23 | ||
| Q1 25 | — | $-6.28 | ||
| Q4 24 | — | $-23.13 | ||
| Q3 24 | — | $-15.70 | ||
| Q2 24 | — | $-7.37 | ||
| Q1 24 | — | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $248.6M | $25.0M |
| 总债务越低越好 | $282.8M | $228.4M |
| 股东权益账面价值 | $1.5B | $-155.2M |
| 总资产 | $2.2B | $656.6M |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资LFSTPIII
| Q4 25 | $248.6M | $25.0M | ||
| Q3 25 | $203.9M | $37.7M | ||
| Q2 25 | $188.9M | $38.6M | ||
| Q1 25 | $134.3M | $40.1M | ||
| Q4 24 | $154.6M | $38.8M | ||
| Q3 24 | $102.6M | $63.0M | ||
| Q2 24 | $87.0M | $73.1M | ||
| Q1 24 | $49.5M | $27.3M |
总债务LFSTPIII
| Q4 25 | $282.8M | $228.4M | ||
| Q3 25 | $284.6M | $252.8M | ||
| Q2 25 | $286.4M | $182.0M | ||
| Q1 25 | $288.2M | $171.1M | ||
| Q4 24 | $290.0M | $108.9M | ||
| Q3 24 | $287.3M | $133.2M | ||
| Q2 24 | $288.0M | $133.1M | ||
| Q1 24 | $288.8M | $118.1M |
股东权益LFSTPIII
| Q4 25 | $1.5B | $-155.2M | ||
| Q3 25 | $1.5B | $-18.7M | ||
| Q2 25 | $1.5B | $44.5M | ||
| Q1 25 | $1.5B | $63.3M | ||
| Q4 24 | $1.4B | $75.9M | ||
| Q3 24 | $1.4B | $120.5M | ||
| Q2 24 | $1.4B | $166.8M | ||
| Q1 24 | $1.4B | $146.6M |
总资产LFSTPIII
| Q4 25 | $2.2B | $656.6M | ||
| Q3 25 | $2.1B | $683.6M | ||
| Q2 25 | $2.1B | $731.6M | ||
| Q1 25 | $2.1B | $783.9M | ||
| Q4 24 | $2.1B | $783.4M | ||
| Q3 24 | $2.1B | $833.3M | ||
| Q2 24 | $2.1B | $892.8M | ||
| Q1 24 | $2.1B | $855.9M |
负债/权益比LFSTPIII
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | 4.09× | ||
| Q1 25 | 0.20× | 2.71× | ||
| Q4 24 | 0.20× | 1.43× | ||
| Q3 24 | 0.20× | 1.11× | ||
| Q2 24 | 0.20× | 0.80× | ||
| Q1 24 | 0.20× | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.6M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | $46.6M | — |
| 自由现金流率自由现金流/营收 | 12.2% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 4.93× | — |
| 过去12个月自由现金流最近4个季度 | $110.0M | — |
8季度趋势，按日历期对齐
经营现金流LFSTPIII
| Q4 25 | $57.6M | $-25.7M | ||
| Q3 25 | $27.3M | $-15.4M | ||
| Q2 25 | $64.4M | $-16.6M | ||
| Q1 25 | $-3.1M | $-33.5M | ||
| Q4 24 | $62.3M | $-57.2M | ||
| Q3 24 | $22.7M | $-22.6M | ||
| Q2 24 | $44.1M | $-10.2M | ||
| Q1 24 | $-21.8M | $-20.0M |
自由现金流LFSTPIII
| Q4 25 | $46.6M | — | ||
| Q3 25 | $17.0M | — | ||
| Q2 25 | $56.6M | — | ||
| Q1 25 | $-10.3M | — | ||
| Q4 24 | $56.0M | — | ||
| Q3 24 | $17.7M | — | ||
| Q2 24 | $39.0M | — | ||
| Q1 24 | $-26.9M | — |
自由现金流率LFSTPIII
| Q4 25 | 12.2% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | -9.0% | — |
资本支出强度LFSTPIII
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.9% | 0.0% | ||
| Q3 24 | 1.6% | 0.0% | ||
| Q2 24 | 1.6% | 0.0% | ||
| Q1 24 | 1.7% | 0.0% |
现金转化率LFSTPIII
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFST
暂无分部数据
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
